SCHEMBL4356141

SCHEMBL4356141

CCCc1nn(Cc2cccc(-c3ccc(N4CCN(C)CC4)nc3)c2)c(=O)c(C(=O)NCC(=O)O)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN3 Q9H6Z9 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 2/20 0.40
EZH2 Q15910 4/20 0.38
EED O75530 2/20 0.38
RBBP4 Q09028 2/20 0.38
SUZ12 Q15022 2/20 0.38
AEBP2 Q6ZN18 2/20 0.38
PIM2 Q9P1W9 1/20 0.38
AOC3 Q16853 1/20 0.37
PRMT3 O60678 1/20 0.37
RBBP7 Q16576 1/20 0.37
SETD7 Q8WTS6 1/20 0.37
EZH1 Q92800 1/20 0.37
FYN P06241 2/20 0.36
HSD11B1 P28845 1/20 0.36
DYRK1A Q13627 1/20 0.36
EGLN1 Q9GZT9 3/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4361545 0.93 EGLN3 (0.46) EGLN3HDAC3HDAC2HDAC8EZH2
SCHEMBL3847256 0.87 HDAC8 (0.42) EGLN3HDAC3HDAC2HDAC8EZH2
SCHEMBL4363479 0.83 NMT1 (0.40) EGLN3
SCHEMBL3849099 0.79 EGLN3 (0.47) EGLN3HDAC3HDAC2HDAC8EZH2
SCHEMBL4361363 0.78 PTGDR2 (0.48) EGLN3EGLN1HIF1A
SCHEMBL4359883 0.77 EGLN3 (0.45) EGLN3HDAC3HDAC2AOC3EGLN1
SCHEMBL4371854 0.74 EGLN3 (0.54) EGLN3EGLN1HIF1A
SCHEMBL4365040 0.73 EGLN3 (0.48) EGLN3EGLN1HIF1A
SCHEMBL4359069 0.73 EGLN3 (0.51) EGLN3HDAC3HDAC2HDAC8EGLN1
SCHEMBL4362443 0.73 EGLN3 (0.52) EGLN3EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2124565-A2 N-SUBSTITUTED GLYCINE DERIVATIVES: HYDROXYLASE INHIBITORS Smithkline Beecham Corporation (US) 2009-12-02 EP claimed
WO-2008089052-A2 N-SUBSTITUTED GLYCINE DERIVATIVES: HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-24 WO claimed